A probable case of sporadic variant Creutzfeldt-Jacob disease with long survival in Peru

Descripción del Articulo

Creutzfeldt-Jakob disease (CJD) is the commonest human prion disease with a reported annual incidence rate of one per million worldwide. CJD has a bad prognosis, and the mean length of survival is 4-6 months. Only 11 cases have been reported in the literature from Perú. Thus, we report a case of a 6...

Descripción completa

Detalles Bibliográficos
Autores: Bancalari-Benavides, Ernesto, Rodriguez-Calienes, Aaron, Camacho, Kiara
Formato: artículo
Fecha de Publicación:2021
Institución:Universidad Nacional Mayor de San Marcos
Repositorio:Revistas - Universidad Nacional Mayor de San Marcos
Lenguaje:español
OAI Identifier:oai:ojs.csi.unmsm:article/19545
Enlace del recurso:https://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/19545
Nivel de acceso:acceso abierto
Materia:Síndrome de Creutzfeldt-Jakob
Enfermedades por Prión
Sobrevida
Perú
Creutzfeldt-Jakob Syndrome
Prion Diseases
Survival
Peru
Descripción
Sumario:Creutzfeldt-Jakob disease (CJD) is the commonest human prion disease with a reported annual incidence rate of one per million worldwide. CJD has a bad prognosis, and the mean length of survival is 4-6 months. Only 11 cases have been reported in the literature from Perú. Thus, we report a case of a 66-year-old male patient with the diagnosis of probable sporadic CJD in whom the survival duration was of 25 months. We identify that the time from disease onset to myoclonus and to reach the akinetic mutism state, the absence of early imaging findings, the delayed cortical and basal ganglia involvement and the supportive therapies implemented were factors that could contribute for the long survival in this patient. 
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).